Biorasi, a leading full-service global CRO, announced the opening of their new Japanese office, located in Tokyo. This milestone marks Biorasi’s first regional headquarters located in East Asia, and expands Biorasi’s capabilities to manage trials in Japan and surrounding territories.
The new office will become the command center for all East-Asian operations.
“We had two major objectives with our Japanese office. The primary objective grew out of our sponsors’ needs for a Japanese component in increasingly complex studies. While a traditional CRO may have simply used a subcontractor, the challenging nature of modern drug trials requires direct management and optimization processes to succeed,” said Dr. Boris Reznik, Chairman of Biorasi. “But additionally, we recognize that Japan is a leader in healthcare innovation, and more than ever Western companies are reaching out to Japanese partners to accelerate the development of their breakthrough products. Opening a Japanese office allows us to better serve the future needs of our sponsors, and fits into our continuing mission to be the partner of choice for companies seeking global, optimized clinical development.”
Biorasi has conducted trials in Japan and other Asian countries for more than a decade through its global CRO partnership network, but the opening of the new corporate office in Japan represents a significant new commitment to supporting both the Asian domestic market and the American and European markets as they collaborate with Japanese pharmaceutical companies.
The Tokyo office is the 6th regional headquarters Biorasi has opened, following Miami, Moscow, Kiev, Dusseldorf, and Mumbai. With growth remaining strong, however, the company looks forward to expanding even further in the near future.
Biorasi is an award-winning Clinical Research Optimized CRO. From study design to execution success, optimization is ingrained in TALOS, the most robust and innovative trial management and optimization platform in the industry. Biorasi’s full-service project teams have help pharmaceutical companies around the world develop numerous drugs, biologics and devices approved by the FDA, EMA and other regulatory agencies.